Enzo BiochemENZB
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 43 institutions reported holding Enzo Biochem Inc. (ENZB) in their 13F filings, up 4 from Q2 2024. 6 opened new positions and 2 sold out. The largest holders were Harbert Fund Advisors, LLC ($5.8M), Renaissance Technologies ($2.8M) and Vanguard Group Inc. ($2.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Enzo Biochem Inc.
- CUSIP
- 294100102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $250K |
| Exits | 2 | $22K |
All 13F filers, Q2 2024 → Q3 2024: 324,982 shares bought and 60,090 shares sold, net +264,892 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| Harbert Fund Advisors, LLC | 4.67% | No change | 5,175,913 | $5.8M |
| Renaissance Technologies | 0.00% | Add +1.1% | 2,527,529 | $2.8M |
| Vanguard Group Inc. | 0.00% | No change | 1,876,622 | $2.1M |
| BlackRock, Inc. | 0.00% | — | 959,151 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +3.3% | 368,646 | $413K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -10.5% | 304,492 | $341K |
| RBF Capital, LLC | 0.01% | No change | 250,359 | $280K |
| Bridgeway Capital Management, LLC | 0.00% | Add +36.9% | 180,800 | $202K |
| State Street Corp. | 0.00% | No change | 154,139 | $173K |
| Wittenberg Investment Management, Inc. | 0.04% | No change | 117,137 | $131K |
| BBR Partners, LLC | 0.01% | New | 100,000 | $112K |
| Nierenberg Investment Management Company, LLC | 0.06% | No change | 88,555 | $99K |
| Morgan Stanley | 0.00% | Add +0.1% | 71,855 | $80K |
| Northern Trust Corp. | 0.00% | No change | 67,204 | $75K |
| Squarepoint Ops LLC | 0.00% | New | 56,646 | $63K |
| Lazard Asset Management LLC | 0.00% | No change | 50,453 | $56K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 44,800 | $51K |
| XTX Topco Ltd | 0.00% | Add +21.6% | 34,354 | $38K |
| Citadel Advisors | 0.00% | New | 26,594 | $30K |
| Kempner Capital Management Inc. | 0.01% | No change | 25,475 | $29K |
| Millennium Management | 0.00% | Add +33.0% | 25,745 | $29K |
| Trivium Point Advisory, LLC | 0.00% | New | 19,500 | $22K |
| FNY Investment Advisers, LLC | 0.01% | New | 20,000 | $22K |
| Raymond James Trust N.A. | 0.00% | No change | 17,016 | $19K |
| Shulman DeMeo Asset Management LLC | 0.00% | No change | 15,487 | $17K |
| Manufacturers Life Insurance Company, The | 0.00% | No change | 14,955 | $17K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,471 | $15K |
| TLS Advisors LLC | 0.03% | No change | 13,616 | $15K |
| Snowden Capital Advisors LLC | 0.00% | Reduce -14.9% | 10,245 | $11K |
| Covestor Ltd | 0.00% | No change | 3,967 | $4K |
| Bfsg, LLC | 0.00% | No change | 2,813 | $3K |
| Simplex Trading, LLC | 0.00% | Add +72.7% | 2,765 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -43.4% | 2,414 | $3K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 2,213 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,833 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -7.5% | 1,000 | $1K |
| Wells Fargo & Company | 0.00% | No change | 578 | $648 |
| FMR LLC | 0.00% | No change | 429 | $480 |
| UBS Group AG | 0.00% | Reduce -61.5% | 278 | $311 |
| Clear Point Advisors Inc. | 0.00% | No change | 120 | $134 |
| Osaic Holdings, Inc. | 0.00% | No change | 120 | $134 |
| BNP Paribas | 0.00% | New | 79 | $88 |
| Sound Income Strategies, LLC | 0.00% | No change | 10 | $11 |
"% of holder's portfolio" is ENZB's weight in each manager's 13F, not the share of Enzo Biochem Inc. the manager owns.